Phase Genomics
Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes.
Launch date
Employees
Market cap
-
Enterprise valuation
€12—18m (Dealroom.co estimates Apr 2023.)
Seattle Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.0m | Seed | ||
$1.5m | Grant | ||
$200k | Grant | ||
$1.5m | Grant | ||
$3.9m | Grant | ||
$1.7m | Grant | ||
* | $5.5m | Grant | |
* | N/A | $3.3m | Debt |
* | N/A | $3.3m | Early VC |
* | $2.5m | Grant | |
* | $1.5m | Grant | |
Total Funding | €20.5m |
Recent News about Phase Genomics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.